R&D/ Views & Analysis/ Views and analysis Rare Disease R&D: one step forward, but a long road ahead Ben Hargreaves Rare Disease Day, rare disease R&D, Rare diseases 0 Comment With over 40% of all medicines in the pipeline aimed at rare diseases, the future looks positive for Share X Rare Disease R&D: one step forward, but a long road ahead https://pharmaphorum.com/r-d/rare-disease-rd-one-step-forward-but-a-long-road-ahead/
